|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/76 | |
| A61K 38/16 | |||
| A61K 35/768 | |||
| A61P 37/00 | |||
| A61K 39/12 |
| (11) | Number of the document | 3008175 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14810447.4 |
| Date of filing the European patent application | 2014-06-15 | |
| (97) | Date of publication of the European application | 2016-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/042444 |
| Date | 2014-06-15 |
| (87) | Number | WO 2014/201449 |
| Date | 2014-12-18 |
| (30) | Number | Date | Country code |
| 201361835545 P | 2013-06-15 | US |
| (72) |
GRUBER, Harry, E., US
JOLLY, Douglas, J., US
LIN, Amy, H., US
|
| (73) |
Tocagen Inc.,
3030 Bunker Hill Street Suite 230, San Diego, CA 92109,
US
|
| (54) | IMMUNOSUPPRESSIVE VIRAL LIKE PARTICLES BASED ON GAMMARETROVIRUS |
| IMMUNOSUPPRESSIVE VIRAL LIKE PARTICLES BASED ON GAMMARETROVIRUS |